Terms: = Skin cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Diagnosis
98 results:
1. Merkel Cell Carcinoma of Unknown Primary Origin.
Francetić H; Simetić L; Tomasović Lončarić Č; Štulhofer Buzina D; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(3):153-155. PubMed ID: 38439727
[TBL] [Abstract] [Full Text] [Related]
2. Penile melanoma: a pathological report of two cases.
Pósfai B; Szentkereszty M; Sánta F; Bajory Z; Simon A; Kozéki Z; Csányi I; Akgul M; Kuthi L
Diagn Pathol; 2023 Oct; 18(1):117. PubMed ID: 37898793
[TBL] [Abstract] [Full Text] [Related]
3. Modern diagnostics and treatment of Merkel cell carcinoma.
Weilandt J; Peitsch WK
J Dtsch Dermatol Ges; 2023 Dec; 21(12):1524-1546. PubMed ID: 37875785
[TBL] [Abstract] [Full Text] [Related]
4. Primary malignant melanoma of the gall bladder masquerading as xanthogranulomatous cholecystitis.
Kumar K; Zaidi A; Husain N; Chandra A
BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37734863
[TBL] [Abstract] [Full Text] [Related]
5. Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy).
Ascierto PA; Agarwala SS; Warner AB; Ernstoff MS; Fox BA; Gajewski TF; Galon J; Garbe C; Gastman BR; Gershenwald JE; Kalinski P; Krogsgaard M; Leidner RS; Lo RS; Menzies AM; Michielin O; Poulikakos PI; Weber JS; Caracò C; Osman I; Puzanov I; Thurin M
J Transl Med; 2023 Jul; 21(1):508. PubMed ID: 37507765
[TBL] [Abstract] [Full Text] [Related]
6. Linear Peptide-Based PET Tracers for Imaging pd-l1 in Tumors.
Zhang L; Zhang S; Wu J; Wang Y; Wu Y; Sun X; Wang X; Shen J; Xie L; Zhang Y; Zhang H; Hu K; Wang F; Wang R; Zhang MR
Mol Pharm; 2023 Aug; 20(8):4256-4267. PubMed ID: 37368947
[TBL] [Abstract] [Full Text] [Related]
7. Brief Communication: Lambert-Eaton Myasthenic Paraneoplastic Syndrome Associated With Merkel Cell Carcinoma Successfully Treated by Immune Checkpoint Inhibitors: 2 Cases.
Gra M; Pham-Ledard A; Gerard E; Dutriaux C; Beylot-Barry M; Duval F; Carla L; Soulages A; Prey S
J Immunother; 2023 Sep; 46(7):276-278. PubMed ID: 37326491
[TBL] [Abstract] [Full Text] [Related]
8. Molecular and clinical correlates of HER3 expression highlights its potential role as a therapeutic target in melanoma.
Shteinman ER; Vergara IA; Rawson RV; Lo SN; Maeda N; Koyama K; da Silva IP; Long GV; Scolyer RA; Wilmott JS; Menzies AM
Pathology; 2023 Aug; 55(5):629-636. PubMed ID: 37286471
[TBL] [Abstract] [Full Text] [Related]
9. Analyses of single extracellular vesicles from non-small lung cancer cells to reveal effects of epidermal growth factor receptor inhibitor treatments.
Stridfeldt F; Cavallaro S; Hååg P; Lewensohn R; Linnros J; Viktorsson K; Dev A
Talanta; 2023 Jul; 259():124553. PubMed ID: 37084607
[TBL] [Abstract] [Full Text] [Related]
10. An epulis-like camrelizumab related reactive cutaneous capillary endothelial proliferation (RCCEP) in the oral cavity: A case report.
Hua Y; Huang X; Li C; Gao N
Oral Oncol; 2023 May; 140():106369. PubMed ID: 36989963
[TBL] [Abstract] [Full Text] [Related]
11. Merkel cell carcinoma: epidemiology, clinical features, diagnosis and treatment of a rare disease.
Siqueira SOM; Campos-do-Carmo G; Dos Santos ALS; Martins C; de Melo AC
An Bras Dermatol; 2023; 98(3):277-286. PubMed ID: 36870886
[TBL] [Abstract] [Full Text] [Related]
12. Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade.
Röbeck P; Franzén B; Cantera-Ahlman R; Dragomir A; Auer G; Jorulf H; Jacobsson SP; Viktorsson K; Lewensohn R; Häggman M; Ladjevardi S
Cytopathology; 2023 Jul; 34(4):286-294. PubMed ID: 36840380
[TBL] [Abstract] [Full Text] [Related]
13. Nivolumab and relatlimab for the treatment of melanoma.
Chen XY; Li YD; Xie Y; Cao LQ; Ashby CR; Zhao H; Chen ZS
Drugs Today (Barc); 2023 Feb; 59(2):91-104. PubMed ID: 36811409
[TBL] [Abstract] [Full Text] [Related]
14. CD8/pd-l1 immunohistochemical reactivity and gene alterations in cutaneous squamous cell carcinoma.
Nishida H; Kondo Y; Kusaba T; Kawamura K; Oyama Y; Daa T
PLoS One; 2023; 18(2):e0281647. PubMed ID: 36780540
[TBL] [Abstract] [Full Text] [Related]
15. Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.
Kawsar A; Edwards C; Patel P; Heywood RM; Gupta A; Mann J; Harland C; Heelan K; Larkin J; Lorigan P; Harwood CA; Matin RN; Fearfield L
Br J Dermatol; 2022 Dec; 187(6):981-987. PubMed ID: 35976170
[TBL] [Abstract] [Full Text] [Related]
16. Metastatic malignant melanoma of the breast: report of a case and review of the literature.
Mastoraki A; Gkiala A; Theodoroleas G; Mouchtouri E; Strimpakos A; Papagiannopoulou D; Schizas D
Folia Med (Plovdiv); 2022 Apr; 64(2):354-358. PubMed ID: 35851793
[TBL] [Abstract] [Full Text] [Related]
17. PD-1, pd-l1, NY-ESO-1, and MAGE-A4 expression in cutaneous angiosarcoma: A case report.
Hashimoto K; Nishimura S; Shinyashiki Y; Ito T; Tanaka H; Ohtani K; Kakinoki R; Akagi M
Medicine (Baltimore); 2022 Jul; 101(28):e29621. PubMed ID: 35839046
[TBL] [Abstract] [Full Text] [Related]
18. Photosensitive rash induced by nivolumab.
Navarro-Triviño FJ; Ruiz-Villaverde R
An Bras Dermatol; 2022; 97(5):648-650. PubMed ID: 35811193
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic accuracy of general dermatologists and supportive oncodermatologists for biopsied cutaneous immune-related adverse events.
Thompson LL; Said JT; Li EB; Yoon J; Krasnow NA; Molina GE; Polyakov NJ; Foreman RK; LeBoeuf NR; Chen ST
Support Care Cancer; 2022 Oct; 30(10):7827-7831. PubMed ID: 35804176
[TBL] [Abstract] [Full Text] [Related]
20. Management of Acral and Mucosal Melanoma: Medical Oncology Perspective.
Jung S; Johnson DB
Oncologist; 2022 Aug; 27(8):703-710. PubMed ID: 35640549
[TBL] [Abstract] [Full Text] [Related]
[Next]